Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111637) titled 'Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the National Health Service (NHS) Care of Multiple Sclerosis' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Queen Mary University of London
Condition:
Multiple Sclerosis
Intervention:
Device: AI software
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: June 14, 2025
Target Sample Size: 1336
Countries of Recruitment:
United Kingdom
To know more, ...